Sanofi India Limited (BOM:500674)
India · Delayed Price · Currency is INR 3,197.40
+10.95 (0.34%)
At close: May 26, 2026
Sanofi India Earnings Call Transcripts
Fiscal Year 2025
-
Transformation year saw flat domestic sales but 1% profit growth, with diabetes segment leading and partnership sales volatile due to inventory effects. Dividend per share proposed at INR 123, up 5%. Focus remains on diabetes, insulin, and operational efficiency.
-
Business transformation focused on diabetes and insulin drove margin expansion and operational efficiency, with double-digit profit growth and improved OpEx ratios. Export sales declined due to site divestment but are being offset by new markets. Interim dividend of INR 75 per share declared.